<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is characterized by an accumulation of multiple congenital anomalies </plain></SENT>
<SENT sid="1" pm="."><plain>Although patients with BWS are known to have a higher incidence of <z:hpo ids='HP_0002898'>embryonal tumors</z:hpo>, there has been no reports associated with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This report describes the case of a patient with BWS who developed <z:hpo ids='HP_0006733'>Acute Megakaryocytic Leukemia</z:hpo> (AMKL,FAB;M7) </plain></SENT>
<SENT sid="3" pm="."><plain>Because most patients with BWS present <z:e sem="disease" ids="C0017547" disease_type="Disease or Syndrome" abbrv="">gigantism</z:e>, the therapy-related toxicity of chemotherapy can be a very serious problem </plain></SENT>
<SENT sid="4" pm="."><plain>This patient exhibited no therapy-related toxicity after chemotherapy, suggesting that <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> with BWS may not require a reduction in dosage </plain></SENT>
</text></document>